MCID: PRT029
MIFTS: 51

Parathyroid Adenoma

Categories: Cancer diseases, Endocrine diseases

Aliases & Classifications for Parathyroid Adenoma

MalaCards integrated aliases for Parathyroid Adenoma:

Name: Parathyroid Adenoma 12 29 55 6 15 73
Adenoma of the Parathyroid Gland 12
Adenoma of Parathyroid 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7608
MeSH 44 D010282
NCIt 50 C3916
UMLS 73 C0262587

Summaries for Parathyroid Adenoma

Disease Ontology : 12 An adenoma that is located in the parathyroid.

MalaCards based summary : Parathyroid Adenoma, also known as adenoma of the parathyroid gland, is related to hyperparathyroidism 1 and hyperparathyroidism 2 with jaw tumors. An important gene associated with Parathyroid Adenoma is CDC73 (Cell Division Cycle 73), and among its related pathways/superpathways are G alpha (s) signalling events and Parathyroid hormone synthesis, secretion and action. The drugs Tramadol and Codeine have been mentioned in the context of this disorder. Affiliated tissues include thyroid, bone and lung, and related phenotypes are endocrine/exocrine gland and cardiovascular system

Wikipedia : 76 A parathyroid adenoma is a benign tumor of the parathyroid gland. It generally causes... more...

Related Diseases for Parathyroid Adenoma

Diseases related to Parathyroid Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 185)
# Related Disease Score Top Affiliating Genes
1 hyperparathyroidism 1 33.2 CDC73 MEN1
2 hyperparathyroidism 2 with jaw tumors 32.6 CASR CCND1 CDC73 MEN1 RET
3 chief cell adenoma 32.1 GCM2 PTH
4 osteitis fibrosa 32.0 BGLAP CALCA CASR PTH
5 adenoma 31.9 CASR CCND1 CDC73 MEN1 RET
6 multiple endocrine neoplasia, type iia 31.9 CALCA CDC73 MEN1 PTH RET
7 parathyroid carcinoma 31.8 CALCA CASR CCND1 CDC73 MEN1 PTH
8 parathyroid transitional clear cell adenoma 30.5 MEN1 PTH
9 multiple endocrine neoplasia 30.1 CALCA CHGA MEN1 RET
10 invasive malignant thymoma 30.0 PTH PTHLH
11 familial hypocalciuric hypercalcemia 30.0 CASR CDC73 PTH
12 zollinger-ellison syndrome 30.0 CHGA MEN1
13 clear cell adenoma 30.0 MEN1 PTH PTHLH
14 rickets 29.9 BGLAP PTH VDR
15 thyroid carcinoma, familial medullary 29.9 CALCA CHGA MEN1 RET
16 pheochromocytoma 29.8 CALCA CHGA MEN1 RET
17 multiple endocrine neoplasia, type i 29.8 CASR CDC73 CDKN2C CHGA MEN1 PTH
18 nephrolithiasis 29.7 CASR PTH VDR
19 hyperparathyroidism 29.7 BGLAP CALCA CASR CDC73 CHGA GCM2
20 lung oat cell carcinoma 29.7 CALCA CHGA
21 thyroid cancer 29.7 BGLAP CALCA CCND1 CHGA RET
22 carcinoid syndrome 29.6 CALCA CHGA MEN1
23 secondary hyperparathyroidism of renal origin 29.6 BGLAP CALCA CASR PTH VDR
24 neuroendocrine tumor 29.6 CALCA CHGA MEN1
25 primary hyperparathyroidism 29.5 BGLAP CALCA CASR CCND1 CDC73 CHGA
26 thyroid cancer, nonmedullary, 2 29.4 CALCA CHGA MEN1 RET
27 bone disease 29.4 BGLAP CALCA CASR PTH PTHLH VDR
28 osteomalacia 29.1 BGLAP CALCA CASR PTH VDR
29 mixed cell type adenoma of parathyroid 12.2
30 birt-hogg-dube syndrome 11.5
31 pancreatitis 10.4
32 thyroid cancer, nonmedullary, 1 10.4
33 papillary carcinoma 10.3
34 goiter 10.3
35 acute pancreatitis 10.3
36 hypocalciuric hypercalcemia, familial, type i 10.3 CASR PTH
37 hypocalciuric hypercalcemia, familial, type ii 10.3 CASR PTH
38 multinodular goiter 10.2
39 oncogenic osteomalacia 10.2 PTH PTHLH
40 axial osteomalacia 10.2 BGLAP PTH
41 liver sarcoma 10.2 CHGA PTHLH
42 carcinoid tumors, intestinal 10.2 CHGA MEN1
43 paragangliomas 1 10.2 CHGA RET
44 hypocalciuric hypercalcemia, familial, type iii 10.2 CASR PTH PTHLH
45 myeloma, multiple 10.2
46 thymoma 10.2
47 adrenal medulla cancer 10.1 CHGA RET
48 hypervitaminosis d 10.1 PTH VDR
49 connective tissue benign neoplasm 10.1 CDC73 PTH
50 tanycytic ependymoma 10.1 CHGA MEN1

Graphical network of the top 20 diseases related to Parathyroid Adenoma:



Diseases related to Parathyroid Adenoma

Symptoms & Phenotypes for Parathyroid Adenoma

MGI Mouse Phenotypes related to Parathyroid Adenoma:

46 (show all 16)
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 10.29 ABCB1 CASR CCND1 CDC73 CDKN2C CHGA
2 cardiovascular system MP:0005385 10.26 ABCB1 CCND1 CDC73 CDKN2C CHGA MEN1
3 cellular MP:0005384 10.25 CASR CCND1 CDC73 CDKN2C GCM2 MEN1
4 growth/size/body region MP:0005378 10.24 ABCB1 CASR CCND1 CDC73 CDKN2C CHGA
5 homeostasis/metabolism MP:0005376 10.23 ABCB1 CASR CCND1 CDC73 CDKN2C CHGA
6 mortality/aging MP:0010768 10.18 ABCB1 CASR CCND1 CDC73 CDKN2C CHGA
7 digestive/alimentary MP:0005381 10.13 ABCB1 CASR CCND1 CDC73 MEN1 PTHLH
8 hematopoietic system MP:0005397 10.13 ABCB1 CASR CCND1 CDC73 CDKN2C PTH
9 immune system MP:0005387 10.13 ABCB1 CASR CCND1 CDC73 CDKN2C MEN1
10 craniofacial MP:0005382 10.08 CCND1 CDC73 GCM2 MEN1 PTH PTHLH
11 nervous system MP:0003631 9.96 ABCB1 CCND1 CDC73 CDKN2C CHGA GCM2
12 muscle MP:0005369 9.85 CASR CDC73 CHGA MEN1 RET VDR
13 neoplasm MP:0002006 9.8 CCND1 CDC73 CDKN2C MEN1 PTHLH RET
14 renal/urinary system MP:0005367 9.76 CASR CDC73 CDKN2C CHGA GCM2 PTHLH
15 reproductive system MP:0005389 9.61 ABCB1 CCND1 CDC73 CDKN2C CHGA MEN1
16 skeleton MP:0005390 9.17 CASR CCND1 CDC73 GCM2 PTH PTHLH

Drugs & Therapeutics for Parathyroid Adenoma

Drugs for Parathyroid Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
2
Codeine Approved, Illicit Phase 4 76-57-3 5284371
3
Acetaminophen Approved Phase 4 103-90-2 1983
4
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
5 Antipyretics Phase 4
6 Analgesics, Non-Narcotic Phase 4
7 Analgesics Phase 4
8 Narcotics Phase 4
9 Respiratory System Agents Phase 4
10 Peripheral Nervous System Agents Phase 4
11 Central Nervous System Depressants Phase 4
12 Chlorpheniramine, phenylpropanolamine drug combination Phase 4
13 Analgesics, Opioid Phase 4
14 Antitussive Agents Phase 4
15
Denosumab Approved Phase 3 615258-40-7
16
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
17 Calcium, Dietary Phase 3,Not Applicable
18 Calciferol Phase 3
19 Vitamins Phase 3
20 Bone Density Conservation Agents Phase 3
21 Hormones Phase 3,Not Applicable
22 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Not Applicable
23 Hormone Antagonists Phase 3,Not Applicable
24 Calcimimetic Agents Phase 3
25 Cinacalcet Hydrochloride Phase 3
26
Choline Approved, Nutraceutical Phase 2 62-49-7 305
27 Lipid Regulating Agents Phase 2
28 Nootropic Agents Phase 2
29 Gastrointestinal Agents Phase 2
30 Antimetabolites Phase 2
31 Hypolipidemic Agents Phase 2
32 Micronutrients
33 Trace Elements
34 Anesthetics
35 Fluorides Not Applicable

Interventional clinical trials:

(show all 22)
# Name Status NCT ID Phase Drugs
1 Minimizing Narcotic Analgesics After Endocrine Surgery Recruiting NCT03469310 Phase 4 Acetaminophen 500Mg Cap;Tylenol #3 Oral Tablet;Tramadol
2 18F-Fluorocholine for the Detection of Parathyroid Adenomas Recruiting NCT03764007 Phase 2, Phase 3 Fluorocholine PET
3 Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. Enrolling by invitation NCT03027557 Phase 3 Cinacalcet 30 mg Tablet;Denosumab Inj 60 mg/ml
4 Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas Completed NCT02432599 Phase 2
5 Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma Unknown status NCT01221896
6 Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI) Unknown status NCT02843542 Not Applicable
7 Evaluation of a New CZT System Unknown status NCT01084356
8 Differentially Expressed Proteins in Sporadic Parathyroid Tumors Unknown status NCT01647503
9 Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism Unknown status NCT01228786
10 Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure Completed NCT01060982 Not Applicable
11 Using X-Ray Dye to Locate Hidden Parathyroid Tumors Completed NCT00001394
12 Minimally Invasive Radioguided Parathyroidectomy Completed NCT01530919
13 Open Versus Video-Assisted Minimal-Invasive Parathyroid Surgery Completed NCT00877981 Not Applicable
14 Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism Recruiting NCT03605472 Not Applicable
15 FCH PET/MRI Parathyroid Localization Recruiting NCT03324893 Not Applicable
16 Molecular and IHC Profiling of PTH Tumors to Evaluate Targeted Agents Recruiting NCT03039439
17 Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas Active, not recruiting NCT01574287 Not Applicable FACBC
18 Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism Active, not recruiting NCT03011736 Not Applicable
19 Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland Not yet recruiting NCT03516747 Not Applicable
20 High Intensity Focused Ultrasound (HIFU) for Parathyroid Adenoma Terminated NCT01291498 Not Applicable
21 Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas Terminated NCT00639405
22 Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism Withdrawn NCT02381925

Search NIH Clinical Center for Parathyroid Adenoma

Genetic Tests for Parathyroid Adenoma

Genetic tests related to Parathyroid Adenoma:

# Genetic test Affiliating Genes
1 Parathyroid Adenoma 29

Anatomical Context for Parathyroid Adenoma

MalaCards organs/tissues related to Parathyroid Adenoma:

41
Thyroid, Bone, Lung, Lymph Node, Thymus, Kidney, Liver

The Foundational Model of Anatomy Ontology organs/tissues related to Parathyroid Adenoma:

19
The Parathyroid

Publications for Parathyroid Adenoma

Articles related to Parathyroid Adenoma:

(show top 50) (show all 1029)
# Title Authors Year
1
A Migratory Mishap: Giant Mediastinal Parathyroid Adenoma. ( 29360437 )
2018
2
Dynamic CT for Parathyroid Adenoma Detection: How Does Radiation Dose Compare With Nuclear Medicine? ( 29629803 )
2018
3
Localization of Parathyroid Adenoma Using Contrast-Enhanced Sonography. ( 29781147 )
2018
4
A Novel Technology for Localization of Parathyroid Adenoma: Ultrasound-Guided Fine Needle Aspiration Combined With Rapid Parathyroid Hormone Detection and Nano-Carbon Technology. ( 29890904 )
2018
5
Severe Acute Pancreatitis as an Index Clinical Manifestation of Parathyroid Adenoma. ( 29888149 )
2018
6
Ectopic Undescended Parathyroid Adenoma-SPECT/CT Avoids False-Negative Interpretation on 99mTc-MIBI Dual-Phase Scintigraphy. ( 29293139 )
2018
7
Role of fine needle aspiration cytology in diagnosis of brown tumor secondary to parathyroid adenoma. ( 29403220 )
2018
8
Clinical value of 11C-methionine positron emission tomography in persistent primary hyperparathyroidism-A case report with a mediastinal parathyroid adenoma. ( 29573598 )
2018
9
Facial Dysmorphism Due to Multiple Brown Tumors Secondary to Large Parathyroid Adenoma, Diagnosed on <sup>99m</sup>Tc-Sestamibi Parathyroid Scintigraphy. ( 29962730 )
2018
10
Cervical haematoma secondary to spontaneous bleeding of parathyroid adenoma. ( 29751932 )
2018
11
Highly specific preoperative selection of solitary parathyroid adenoma cases in primary hyperparathyroidism by quantitative image analysis of the early-phase Technetium-99m sestamibi scan. ( 29877611 )
2018
12
Localisation of ectopic mediastinal parathyroid adenoma by 18F-fluorocholine PET/CT. ( 29592976 )
2018
13
Parathyroid, Adenoma ( 29939647 )
2018
14
Incidental Detection of Parathyroid Adenoma on Somatostatin Receptor PET/CT and Incremental RoleA of <sup>18</sup>F-Fluorocholine PET/CT in MEN1 Syndrome. ( 29942404 )
2018
15
[<sup>18</sup>F]Fluorocholine Uptake of Parathyroid Adenoma Is Correlated with Parathyroid Hormone Level. ( 29508264 )
2018
16
An Unusual Mass of Posterior Mediastinum: A Case of Retrotracheal Parathyroid Adenoma Presenting With Primary Hyperparathyroidism. ( 30479491 )
2018
17
Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT CT and Multiphase Multidetector 4D CT. ( 30523145 )
2018
18
Thoracoscopic removal of ectopic mediastinal parathyroid adenoma causing hyperparathyroidism: a rare entity. ( 30524629 )
2018
19
Adult type rhabdomyoma presenting as a parathyroid adenoma. ( 30537102 )
2018
20
Huge Ectopic Parathyroid Adenoma. ( 30551697 )
2018
21
Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. ( 30239472 )
2018
22
Primary Hyperparathyroidism due to Parathyroid Adenoma Originated from Supernumerary Gland. ( 30275995 )
2018
23
Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples. ( 30284223 )
2018
24
Twin pregnancy with triple parathyroid adenoma: A case report and review of literature. ( 30294612 )
2018
25
An initial evaluation of hypokalemia turned out distal renal tubular acidosis secondary to parathyroid adenoma. ( 30381523 )
2018
26
Mediastinal ectopic parathyroid adenoma. ( 30398661 )
2018
27
A Rare Case of Primary Hyperparathyroidism Caused by a Giant Solitary Parathyroid Adenoma. ( 30405093 )
2018
28
Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging. ( 30418208 )
2018
29
Autoinfarction of Giant Parathyroid Adenoma after Preoperative Withdrawal of Anticoagulants. ( 30425877 )
2018
30
Focused parathyroidectomy for single parathyroid adenoma: a clinical account of 20 patients. ( 30034666 )
2018
31
A SURPRISE ENCOUNTER IN RENAL TRANSPLANT EVALUATION: MEDIASTINAL PARATHYROID ADENOMA. ( 30035624 )
2018
32
The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience. ( 30123260 )
2018
33
SPECT-CT-guided ultrasound for parathyroid adenoma localisation - a one stop approach. ( 30139883 )
2018
34
Feasibility of bipolar radiofrequency ablation in patients with parathyroid adenoma: a first evaluation. ( 29607692 )
2018
35
Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT. ( 29662564 )
2018
36
Transoral robotic resection of a retropharyngeal parathyroid adenoma: a case report. ( 29987624 )
2018
37
Case report: incidental parathyroid adenoma in a Chinese diabetic patient with hypercalcemia and normal parathyroid hormone levels. ( 29995768 )
2018
38
Thoracoscopic approach in the treatment of ectopic thymic parathyroid adenoma. ( 30002763 )
2018
39
Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT. ( 29393930 )
2018
40
An occult ectopic parathyroid adenoma in a pediatric patient: a case report and management algorithm. ( 28809753 )
2017
41
Molecular profiles of oxyphilic and chief cell parathyroid adenoma. ( 28986304 )
2017
42
Management of mediastinal parathyroid adenoma via minimally invasive thoracoscopic surgery: Case report. ( 28988020 )
2017
43
Decrease in size and activity of parathyroid adenoma after ultrasound guided biopsy. ( 28914043 )
2017
44
Parathyroid adenoma with concurrent toxic thyroid adenoma: a rare combination. ( 28876558 )
2017
45
Ureteropelvic Junction Obstruction and Parathyroid Adenoma: Coincidence or Link? ( 29181209 )
2017
46
Percutaneous Transsternal Cryoablation of Ectopic Parathyroid Adenoma in the Anterior Mediastinum. ( 29264453 )
2017
47
Percentage arterial enhancement: An objective index for accurate identification of parathyroid adenoma/hyperplasia inA primary hyperparathyroidism. ( 28656592 )
2017
48
A Herald of Plasma Cell Myeloma: A Report of Malignant Plasma Cells Identified in Parathyroid Adenoma and a Review of Non-parathyroid Malignancies in Parathyroid Glands. ( 29030756 )
2017
49
Surgery for Ectopic Parathyroid Adenoma in Lower Part of Superior Mediastinum through a Transcervical Incision. ( 28524839 )
2017
50
Primary hyperparathyroidism caused by mediastinal ectopic parathyroid adenoma. ( 28775222 )
2017

Variations for Parathyroid Adenoma

ClinVar genetic disease variations for Parathyroid Adenoma:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 CDC73 CDC73, 4-BP DEL, 685AGAG deletion Pathogenic
2 CASR NM_000388.3(CASR): c.2449G> A (p.Val817Ile) single nucleotide variant Likely pathogenic rs1057518933 GRCh37 Chromosome 3, 122003250: 122003250
3 CASR NM_000388.3(CASR): c.2449G> A (p.Val817Ile) single nucleotide variant Likely pathogenic rs1057518933 GRCh38 Chromosome 3, 122284403: 122284403
4 MEN1 NM_000244.3(MEN1): c.669+1delG deletion Pathogenic rs1057518903 GRCh37 Chromosome 11, 64575362: 64575362
5 MEN1 NM_000244.3(MEN1): c.669+1delG deletion Pathogenic rs1057518903 GRCh38 Chromosome 11, 64807890: 64807890
6 MEN1 NM_000244.3(MEN1): c.371_372delTC (p.Val124Aspfs) deletion Pathogenic GRCh38 Chromosome 11, 64809738: 64809739
7 MEN1 NM_000244.3(MEN1): c.371_372delTC (p.Val124Aspfs) deletion Pathogenic GRCh37 Chromosome 11, 64577210: 64577211

Copy number variations for Parathyroid Adenoma from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 25580 1 191357783 191487679 Loss HRPT2 Parathyroid adenoma
2 33979 1 51206195 51212897 Loss CDKN2C Parathyroid adenoma
3 33993 1 51300000 56200000 Loss RNF11 Parathyroid adenoma
4 48482 11 1 48800000 Losse MEN1 Parathyroid adenoma
5 192952 5 121500000 127300000 Gaine LMNB1 Parathyroid adenoma
6 192953 5 121500000 127300000 Gaine PIK3R1 Parathyroid adenoma

Expression for Parathyroid Adenoma

Search GEO for disease gene expression data for Parathyroid Adenoma.

Pathways for Parathyroid Adenoma

GO Terms for Parathyroid Adenoma

Biological processes related to Parathyroid Adenoma according to GeneCards Suite gene sharing:

(show all 20)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription by RNA polymerase II GO:0000122 9.97 CCND1 CDC73 MEN1 PTH VDR
2 negative regulation of cell proliferation GO:0008285 9.8 CDC73 CDKN2C MEN1 PTHLH VDR
3 response to organic cyclic compound GO:0014070 9.7 BGLAP CASR CCND1
4 response to ethanol GO:0045471 9.67 BGLAP CCND1 PTH
5 adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189 9.65 CALCA PTH PTHLH
6 skeletal system development GO:0001501 9.62 BGLAP PTH PTHLH VDR
7 beta-catenin-TCF complex assembly GO:1904837 9.59 CDC73 MEN1
8 negative regulation of cyclin-dependent protein serine/threonine kinase activity GO:0045736 9.58 CDKN2C MEN1
9 decidualization GO:0046697 9.58 MEN1 VDR
10 response to pain GO:0048265 9.56 CALCA RET
11 response to vitamin D GO:0033280 9.55 BGLAP PTH
12 response to drug GO:0042493 9.55 ABCB1 BGLAP CCND1 PTH RET
13 vasodilation GO:0042311 9.54 CALCA CASR
14 bone mineralization GO:0030282 9.54 BGLAP PTH PTHLH
15 negative regulation of chondrocyte differentiation GO:0032331 9.51 PTH PTHLH
16 cellular response to vitamin D GO:0071305 9.46 BGLAP CASR
17 response to fibroblast growth factor GO:0071774 9.43 CASR PTH
18 cAMP metabolic process GO:0046058 9.26 PTH PTHLH
19 osteoblast development GO:0002076 9.13 BGLAP MEN1 PTHLH
20 cellular calcium ion homeostasis GO:0006874 9.02 CALCA CASR GCM2 PTH VDR

Molecular functions related to Parathyroid Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.13 CALCA PTH PTHLH
2 peptide hormone receptor binding GO:0051428 8.62 PTH PTHLH

Sources for Parathyroid Adenoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....